Analysts Estimate Report : What to Look Out for Actinium Pharmaceuticals (NASDAQ:ATNM)

0
1301

Earnings results for Actinium Pharmaceuticals (NASDAQ:ATNM)

Actinium Pharmaceuticals, Inc. is estimated to report earnings on 09/04/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.51. The reported EPS for the same quarter last year was $-0.9.

Analyst Opinion on Actinium Pharmaceuticals (NASDAQ:ATNM)

1 Wall Street analysts have issued ratings and price targets for Actinium Pharmaceuticals in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

There is not enough analysis data for Actinium Pharmaceuticals.

Dividend Strength: Actinium Pharmaceuticals (NASDAQ:ATNM)

Actinium Pharmaceuticals does not currently pay a dividend. Actinium Pharmaceuticals does not have a long track record of dividend growth.

Insiders buying/selling: Actinium Pharmaceuticals (NASDAQ:ATNM)

In the past three months, Actinium Pharmaceuticals insiders have not sold or bought any company stock.

Earnings and Valuation of Actinium Pharmaceuticals (NASDAQ:ATNM

More latest stories: here